GPS Wealth Strategies Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
GPS Wealth Strategies Group's NVO Position: Q4 2025 in Review
GPS Wealth Strategies Group reduced its Novo Nordisk (NVO) stake by 75% in Q4 2025, selling an estimated $185K and leaving 1,201 shares worth $61.1K. The position accounts for 0.05% of the portfolio, ranked #198.
GPS Wealth Strategies Group first reported a position in NVO in Q1 2021 and has held it in 19 quarters since. The position peaked at $824K in Q2 2024. 1,419 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- GPS Wealth Strategies Group held 1,201 shares of Novo Nordisk worth $61.1K as of Q4 2025.
- GPS Wealth Strategies Group sold 3,620 Novo Nordisk shares in Q4 2025, an estimated $185K.
- Novo Nordisk made up 0.05% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #198 holding.
- GPS Wealth Strategies Group first reported a position in Novo Nordisk in Q1 2021 and has held it in 19 quarters since.
- GPS Wealth Strategies Group's Novo Nordisk position peaked at $824K in Q2 2024.
- 1,419 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.